Clinical trial
Trial of Growth Hormone Therapy in Pediatric Crohn's Disease
NCT00109473 · Children's Hospital Medical Center, Cincinnati, Other · Completed
Key facts
| NCT number | NCT00109473 |
|---|---|
| Title | Trial of Growth Hormone Therapy in Pediatric Crohn's Disease |
| Official title | A Phase II Randomized Trial of Growth Hormone Therapy in Pediatric Crohn's Disease |
| Lead sponsor | Children's Hospital Medical Center, Cincinnati, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Crohn's Disease |
| Intervention type | Drug |
| Interventions | growth hormone, cortecosteroid |
| Enrollment | 22 |
| Start date | Apr 1, 2005 |
| Primary completion | Jul 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | Apr 29, 2005 |
| Last update posted | Oct 30, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: